Convergent Neuroimaging and Molecular Signatures in Mild Cognitive Impairment and Alzheimer's Disease: A Data-Driven Meta-Analysis with <i>N</i>=3,118

doi:10.1007/s12264-024-01218-x

	Convergent Neuroimaging and Molecular Signatures in Mild Cognitive Impairment and Alzheimer's Disease: A Data-Driven Meta-Analysis with N=3,118
	Kang, Xiaopeng 1,2,3; Wang, Dawei 4; Lin, Jiaji 5,6; Yao, Hongxiang 7; Zhao, Kun8 ; Song, Chengyuan 9; Chen, Pindong1,2,3 ; Qu, Yida1,2,3 ; Yang, Hongwei 10; Zhang, Zengqiang 11; Zhou, Bo12 ; Han, Tong 13; Liao, Zhengluan 14; Chen, Yan 3,14; Lu, Jie 10; Yu, Chunshui 15; Wang, Pan16 ; Zhang, Xinqing 17; Li, Ming18 ; Zhang, Xi12 ; Jiang, Tianzi1,2,3 ; Zhou, Yuying 16; Liu, Bing1,2,3,19 ; Han, Ying 17,20,21; Liu, Yong1,2,8
发表期刊	NEUROSCIENCE BULLETIN
ISSN	1673-7067
	2024-06-01
页码	13
通讯作者	Han, Ying(hanying@xwh.ccmu.edu.cn) ; Liu, Yong(yongliu@bupt.edu.cn)
摘要	The current study aimed to evaluate the susceptibility to regional brain atrophy and its biological mechanism in Alzheimer's disease (AD). We conducted data-driven meta-analyses to combine 3,118 structural magnetic resonance images from three datasets to obtain robust atrophy patterns. Then we introduced a set of radiogenomic analyses to investigate the biological basis of the atrophy patterns in AD. Our results showed that the hippocampus and amygdala exhibit the most severe atrophy, followed by the temporal, frontal, and occipital lobes in mild cognitive impairment (MCI) and AD. The extent of atrophy in MCI was less severe than that in AD. A series of biological processes related to the glutamate signaling pathway, cellular stress response, and synapse structure and function were investigated through gene set enrichment analysis. Our study contributes to understanding the manifestations of atrophy and a deeper understanding of the pathophysiological processes that contribute to atrophy, providing new insight for further clinical research on AD.
关键词	Alzheimer's disease Structural magnetic resonance imaging Meta-analysis Brain atrophy Gene set enrichment analysis
DOI	10.1007/s12264-024-01218-x
关键词[WOS]	UNFOLDED PROTEIN RESPONSE ; HIPPOCAMPAL NEURONAL LOSS ; 5-HT1A RECEPTORS ; CORTICAL THICKNESS ; MATTER LOSS ; DEMENTIA ; ATROPHY ; BRAIN ; MRI ; MECHANISMS
收录类别	SCI
语种	英语
资助项目	Science and Technology Innovation[2022ZD0211600] ; Fundamental Research Funds for the Central Universities[2021XD-A03] ; National Natural Science Foundation of China[61633018] ; National Natural Science Foundation of China[81571062] ; National Natural Science Foundation of China[81400890] ; National Natural Science Foundation of China[81471120] ; National Natural Science Foundation of China[81701781] ; National Natural Science Foundation of China[81901101] ; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)[U01 AG024904] ; DOD ADNI (Department of Defense)[W81XWH-12-2-0012] ; National Institute on Aging ; National Institute of Biomedical Imaging and Bioengineering ; Alzheimer's Association ; Alzheimer's Drug Discovery Foundation ; Araclon Biotech ; Biogen ; CereSpir, Inc. ; Cogstate ; Elan Pharmaceuticals, Inc. ; EuroImmun ; F. Hoffmann-La Roche Ltd ; Fujirebio ; IXICO Ltd. ; Johnson & Johnson Pharmaceutical Research & Development LLC. ; Merck Co., Inc. ; Meso Scale Diagnostics ; NeuroRx Research ; Pfizer Inc. ; Piramal Imaging ; Canadian Institutes of Health Research ; ADNI clinical sites in Canada ; Foundation for the National Institutes of Health ; Northern California Institute for Research and Education ; Laboratory for Neuro Imaging at the University of Southern California
项目资助者	Science and Technology Innovation ; Fundamental Research Funds for the Central Universities ; National Natural Science Foundation of China ; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) ; DOD ADNI (Department of Defense) ; National Institute on Aging ; National Institute of Biomedical Imaging and Bioengineering ; Alzheimer's Association ; Alzheimer's Drug Discovery Foundation ; Araclon Biotech ; Biogen ; CereSpir, Inc. ; Cogstate ; Elan Pharmaceuticals, Inc. ; EuroImmun ; F. Hoffmann-La Roche Ltd ; Fujirebio ; IXICO Ltd. ; Johnson & Johnson Pharmaceutical Research & Development LLC. ; Merck Co., Inc. ; Meso Scale Diagnostics ; NeuroRx Research ; Pfizer Inc. ; Piramal Imaging ; Canadian Institutes of Health Research ; ADNI clinical sites in Canada ; Foundation for the National Institutes of Health ; Northern California Institute for Research and Education ; Laboratory for Neuro Imaging at the University of Southern California
WOS研究方向	Neurosciences & Neurology
WOS类目	Neurosciences
WOS记录号	WOS:001236799700001
出版者	SPRINGER
引用统计
文献类型	期刊论文
条目标识符	http://ir.ia.ac.cn/handle/173211/58693
专题	脑图谱与类脑智能实验室_脑网络组研究
通讯作者	Han, Ying; Liu, Yong
作者单位	1.Univ Chinese Acad Sci, Sch Artificial Intelligence, Beijing 100049, Peoples R China 2.Chinese Acad Sci, Inst Automat, Brainnetome Ctr, Beijing 100190, Peoples R China 3.Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing 100190, Peoples R China 4.Shandong Univ, Dept Radiol, Qilu Hosp, Jinan 250063, Peoples R China 5.Air Force Med Univ, Affiliated Hosp 2, Dept Neurol, Xian 710032, Peoples R China 6.Chinese Peoples Liberat Army Gen Hosp, Dept Radiol, Beijing 100853, Peoples R China 7.Chinese Peoples Liberat Army Gen Hosp, Med Ctr 2, Natl Clin Res Ctr Geriatr Dis, Dept Radiol, Beijing 100853, Peoples R China 8.Beijing Univ Posts & Telecommun, Sch Artificial Intelligence, Beijing 100191, Peoples R China 9.Shandong Univ, Dept Neurol, Qilu Hosp, Jinan 250063, Peoples R China 10.Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing 100053, Peoples R China 11.Branch Chinese PLA Gen Hosp, Sanya 572013, Peoples R China 12.Chinese Peoples Liberat Army Gen Hosp, Med Ctr 2, Natl Clin Res Ctr Geriatr Dis, Dept Neurol, Beijing 100853, Peoples R China 13.Tianjin Huanhu Hosp, Dept Radiol, Tianjin 300222, Peoples R China 14.Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Peoples Hosp, Dept Psychiat, Hangzhou 310014, Peoples R China 15.Tianjin Med Univ Gen Hosp, Dept Radiol, Tianjin 300070, Peoples R China 16.Tianjin Huanhu Hosp, Dept Neurol, Tianjin 300222, Peoples R China 17.Capital Med Univ, Dept Neurol, Xuanwu Hosp, Beijing 100053, Peoples R China 18.Chinese Acad Sci, Kunming Inst Zool, Human Dis Mech Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models, Kunming 650201, Yunnan, Peoples R China 19.Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China 20.Natl Clin Res Ctr Geriatr Disorders, Beijing 100053, Peoples R China 21.Beijing Inst Brain Disorders, Ctr Alzheimers Dis, Beijing 100053, Peoples R China
第一作者单位	中国科学院自动化研究所; 模式识别国家重点实验室
通讯作者单位	中国科学院自动化研究所
推荐引用方式 GB/T 7714	Kang, Xiaopeng,Wang, Dawei,Lin, Jiaji,et al. Convergent Neuroimaging and Molecular Signatures in Mild Cognitive Impairment and Alzheimer's Disease: A Data-Driven Meta-Analysis with N=3,118[J]. NEUROSCIENCE BULLETIN,2024:13.
APA	Kang, Xiaopeng.,Wang, Dawei.,Lin, Jiaji.,Yao, Hongxiang.,Zhao, Kun.,...&Liu, Yong.(2024).Convergent Neuroimaging and Molecular Signatures in Mild Cognitive Impairment and Alzheimer's Disease: A Data-Driven Meta-Analysis with N=3,118.NEUROSCIENCE BULLETIN,13.
MLA	Kang, Xiaopeng,et al."Convergent Neuroimaging and Molecular Signatures in Mild Cognitive Impairment and Alzheimer's Disease: A Data-Driven Meta-Analysis with N=3,118".NEUROSCIENCE BULLETIN (2024):13.